Hardly any retrace possible with
1) the current uncertainty about FDA investigation
2) general sell decline of the testosterone market
3) Axiron not improving market share.
Any retrace would only happen when 1) has been removed and therefore 2) & 3) will improve.
If 2) continue to deteriorate then I doubt Ell Lily will put more time, money and effort in marketing the product to try improve the market share.
